Related Experiment Video

Updated: Aug 20, 2026

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

Chlamydia pneumoniae and coronary artery disease: legitimized linkages?

John P Higgins1, Johanna A Higgins, Patricia M Higgins

  • 1Harvard Medical School, Brigham and Women's Hospital, Cardiology Section, 4C108, VA Boston Healthcare System, 1400 VFW Parkway, Boston, MA 02132, USA. John.Higgins@med.va.gov

Expert Review of Cardiovascular Therapy
|March 20, 2004
PubMed

Insights

Early life Chlamydia pneumoniae (Cp) infection may accelerate atherosclerosis and cardiovascular issues later in life. Antibiotic treatment for Cp shows potential in reducing infection, inflammation, and cardiovascular complications.

Area of Science:

  • Infectious disease
  • Cardiovascular science
  • Immunology

Background:

  • Chlamydia pneumoniae (Cp) infection in early life is a potential contributor to atherosclerosis development.
  • Cp infection may induce endothelial dysfunction and modulate inflammatory pathways involved in atherosclerosis.
  • Synergistic effects with other infections could exacerbate Cp's role in atherosclerosis.

Purpose of the Study:

  • To explore the link between early-life Chlamydia pneumoniae infection and the acceleration of atherosclerosis.
  • To investigate the mechanisms by which Cp infection influences endothelial function and inflammation.
  • To evaluate the impact of antibiotic treatment for Cp on atherosclerosis progression and cardiovascular outcomes.

Main Methods:

  • Review of epidemiological studies linking early Chlamydia pneumoniae infection to long-term cardiovascular health.
  • Analysis of cellular and molecular mechanisms of Cp's effect on endothelial cells and inflammatory markers.
  • Examination of clinical data from antibiotic treatment trials for Chlamydia pneumoniae.

Main Results:

  • Evidence suggests Chlamydia pneumoniae infection in early life may accelerate atherosclerosis over decades.
  • Cp infection is associated with endothelial dysfunction and modulation of inflammation.
  • Antibiotic treatment for Cp infection has been linked to reduced infection rates, inflammation, and cardiovascular complications in some studies.

Conclusions:

  • Chlamydia pneumoniae is a biologically plausible candidate for causing atherosclerosis.
  • Concurrent infections may potentiate the atherogenic effects of Cp.
  • Antibiotic interventions targeting Chlamydia pneumoniae show promise in mitigating atherosclerosis and cardiovascular disease risk.

More Related Videos

Forward Genetic Approaches in Chlamydia trachomatis09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Related Concept Videos

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...